Navigation Links
Pregnant patients lose out in breast cancer treatment; a new approach is needed
Date:4/16/2008

Berlin, Germany: Pregnant breast cancer patients can be treated as closely as possible to existing guidelines for non-pregnant patients, with few ill effects, a scientist told the 6th European Breast Cancer Conference (EBCC-6) today (Wednesday 16 April).

Dr. Sibylle Loibl, Assistant Professor in Obstetrics and Gynaecology at University of Frankfurt, Germany, and a member of the German Breast Group, said that until now, evidence upon which decisions on treatment for pregnant patients could be made was limited, and that a cautious approach by doctors meant that many women did not get the best treatment for their cancer. We realised that there are hardly any data on this subject, she said, and therefore set out to collect information from patients in Germany and throughout Europe.

The German Breast Group launched a data-collection exercise in 2003. Information on 122 pregnant patients diagnosed with breast cancer between April 2003 and December 2007 was analysed for a number of factors foetal outcome four weeks after delivery, maternal outcome of pregnancy, stage and biological characteristics of the breast cancer, breast cancer therapy, sensitivity and specificity of diagnostic procedures, outcome of the child five years later, and outcome of the breast cancer five years after diagnosis.

The median gestational age at the time of diagnosis was 21 weeks, and the median age of the women 33 years. Some patients chose not to continue the pregnancy on learning of their diagnosis, but of those who did, 33.3% received surgery only, 43.2% were treated by surgery and chemotherapy, 5.4% by chemotherapy alone, and 2.7% had no treatment at all. The median time for delivery was 36 weeks, slightly earlier than that which is normal in healthy women. Although there were some health problems among the newborn babies, they were generally minor, and the foetal outcome in babies whose mothers received chemotherapy was not different to those whose
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Humans unknowing midwives for pregnant moose
2. Pregnant women at risk for unnecessary operations due to misdiagnosis of appendicitis
3. Abnormal fat metabolism underlies heart problems in diabetic patients
4. A new radiation therapy treatment developed for head and neck cancer patients
5. Device helps patients survive, regain function til transplant
6. Diet support helps chronic kidney patients
7. Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials
8. Doctors learn to control their own brains pain responses to better treat patients
9. Jefferson urologists studying regenerated neo-bladder to help spinal cord injury patients
10. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
11. New class of drug offers hope to treatment-resistant AIDS patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... the life of a cell, the response to DNA damage de...pair itself, commit suicide, or grow uncontrollabl...ished in the July 25th issue of Cell , scientists...ay that cells respond to DNA damage through a proc...g points to a new pathway for the development of c...
(Date:7/24/2008)... Proteins (NSP), a new family of genes discovered ...Research and Molecular Medicine in Temple Universi...nvolved in apoptosis or programmed cell death. , ...ng, then a doctoral student at the University and ...versity and the Cardeza Foundation, and Antonio Gi...
(Date:7/23/2008)...to a domestic renewable fuel source could generate...f North America,s entire consumption needs and lea...ssions (GHGs), according to US research published ...ics, Environmental Research Letters . , The jou...enefits of Converting Manure to Biogas, has impli...
(Date:7/23/2008)... shows that popular fish oil supplements have an e...s in human skin. But whether that effect is detrim... a mystery. , The omega-3 fatty acids found in f...scular health and other diseases related to chroni...properties. But insufficient inflammation during t...
Breaking Biology News(10 mins):A new cellular pathway linked to cancer is identified by NYU researchers 2Novel structure proteins could play a role in apoptosis 2Cow power could generate electricity for millions 2Scientists suspect omega-3 fatty acids could slow acute wound healing 2Scientists suspect omega-3 fatty acids could slow acute wound healing 3Scientists suspect omega-3 fatty acids could slow acute wound healing 4Former Biolase CEO 26 EVP Launch Technology4Medicine 12411 1Former Biolase CEO 26 EVP Launch Technology4Medicine 12411 2Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 1Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 2Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 3Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 4Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 5Phlo Reports Sharp Revenue Increase 3441 1Phlo Reports Sharp Revenue Increase 3441 2Cancer Cure Coalition Proposes Major Changes at the FDA 1404 1Cancer Cure Coalition Proposes Major Changes at the FDA 1404 2Cancer Cure Coalition Proposes Major Changes at the FDA 1404 3
...rotects against HIV increases the risk of developi...o a new study appearing online on January 9th in T...n in question is a small deletion in a gene that e... in 1996 as a co-receptor used by HIV to infect ce... (CCR5delta32) are highly resistant to HIV infecti...
...hich humans and which chimpanzees can taste bitter...y influence nutritional choices and ultimately the...For chimpanzees, it provides a way to live safely ... other harmful compounds. , Research conducted mor...Ronald Aylmer Fisher, the eminent British statisti...
...and Michael Emerman and colleagues at the Fred Hut...urprisingly large fraction of humans may be impair... the body,s defense against invading retroviruses ..."intrinsic immunity" is encoded by the TRIM5 gene....RIM5 possessed by rhesus macaques allows them to r...
... important model organisms for molecular science t...ch the most is known. The genes of higher-level pl...d by their similarity to E. coli genes. As such, ...ormation is of great importance to the scientific ...forts of scientists working independently on the g...
Other Biology News:Genetic mutation linked to West Nile virus infection 2Research updates 65-year-old genetic discovery 2Research updates 65-year-old genetic discovery 3MBL leads effort to update E. coli genome 2
(Date:7/24/2008)... Calif., July 24 /- Poniard...maceutical company focused,on oncology, today anno...ss,the Company,s second quarter results and provid...linical development plan for picoplatin, the,Compa... chairman and chief,executive officer, Ronald A. M...
(Date:7/24/2008)... 24 /- Cara Therapeutics, Inc.,announ...dditional funding,to its original $24 million Seri...und was led by new investor, Devon Park Bioventure...ations. Previous investors participating,in the ro...hi International,Corporation and Wistar Morris. In...
(Date:7/24/2008)...ly 24 /- Sagent Pharmaceuticals, Inc....y, today announced that it,has launched ceftazidim...um, beta-lactam antibiotic. Sagent will offer ceft...acy bulk package vials. According to,IMS data, 200...tes were,approximately $45.7 million., "Sagent is...
(Date:7/24/2008)...- Monsanto Company (NYSE:,M...y approvals for Roundup,Ready 2 Yield(TM) soybeans..., the company noted the European Food Safety Autho...on concluding Roundup Ready 2 Yield is,safe for im...ns are the,second generation of the popular Roundu...
Breaking Biology Technology:Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31 2Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch 2
...he eve of departing for Osaka, Japan, for the Bio...s mission. I have written a number of times over t...h industries, but I haven,t been back to Japan for... to speed on the development of the biotech indust...e sister cities and my last visit was part of the ...
...s. - Wisconsin high-school students are again am...ll on the ACT , a major college preparedness test...e, Wisconsin ranked second nationally among states... one percentage point behind first-place Minnesota...the quality of Wisconsin,s schools, all states, fr...
...s. - InvivoSciences LLC , a startup biotechnolog...to help drug developers bridge the gap between mol... studying heart diseases, skin disorders, and othe...em could provide that bridge. , ,Using tissues der... a recent meeting of the Wisconsin Biotechnology ...
...s. - Wisconsin can create a dynamic, creative eco...axes and shedding its "welfare state" mentality, t...f business executives. , ,John Jazwiec, who earlie...state,s business climate, outlined what he acknowl...nds Breakfast of the Independent Business Associa...
Other Biology Technology:Chinese pharma-biotech dragon rears its head 2Chinese pharma-biotech dragon rears its head 3Chinese pharma-biotech dragon rears its head 4Chinese pharma-biotech dragon rears its head 5Chinese pharma-biotech dragon rears its head 6Wisconsin students test well on ACT, but relatively few are ready for college rigors 2Wisconsin students test well on ACT, but relatively few are ready for college rigors 3Biotech firm uses live heart tissue in drug screens 2Biotech firm uses live heart tissue in drug screens 3RedPrairie exec calls for 50 percent tax cut 2RedPrairie exec calls for 50 percent tax cut 3RedPrairie exec calls for 50 percent tax cut 4
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units
adult
DNA Purification
Porcine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11
Biology Products: